561 related articles for article (PubMed ID: 10720968)
1. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW
Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mycophenolate mofetil in renal transplant recipients on peritoneal dialysis.
Morgera S; Neumayer HH; Fritsche L; Kuchinke S; Lampe D; Ahnert V; Bauer S; Mai I; Budde K
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):159-63. PubMed ID: 9562232
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE; Nicholls AJ; Kamm BR
Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.
Johnson HJ; Swan SK; Heim-Duthoy KL; Nicholls AJ; Tsina I; Tarnowski T
Clin Pharmacol Ther; 1998 May; 63(5):512-8. PubMed ID: 9630824
[TBL] [Abstract][Full Text] [Related]
5. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysis.
Morgera S; Budde K; Lampe D; Ahnert V; Fritsche L; Kuchinke S; Neumayer HH
Transpl Int; 1998; 11(1):53-7. PubMed ID: 9503555
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.
Liang MZ; Lu YP; Nan F; Li YP
Transplant Proc; 2006 Sep; 38(7):2044-7. PubMed ID: 16979994
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children.
Jacqz-Aigrain E; Khan Shaghaghi E; Baudouin V; Popon M; Zhang D; Maisin A; Loirat C
Pediatr Nephrol; 2000 Feb; 14(2):95-9. PubMed ID: 10684355
[TBL] [Abstract][Full Text] [Related]
9. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies.
Jiao Z; Zhong JY; Zhang M; Shi XJ; Yu YQ; Lu WY
Eur J Clin Pharmacol; 2007 Jan; 63(1):27-37. PubMed ID: 17093994
[TBL] [Abstract][Full Text] [Related]
10. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.
Morissette P; Albert C; Busque S; St-Louis G; Vinet B
Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
12. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
Jain AB; Hamad I; Zuckerman S; Zhang S; Warty VS; Fung JJ; Venkataramanan R
Liver Transpl Surg; 1999 Mar; 5(2):101-6. PubMed ID: 10071348
[TBL] [Abstract][Full Text] [Related]
13. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
14. Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function.
Wigger M; Armstrong VW; Shipkova M; Wacke R; Nizze H; Streit F; von Ahsen N; Muscheites J; Glasenapp S; Stolpe HJ; Oellerich M
Ther Drug Monit; 2002 Jun; 24(3):438-43. PubMed ID: 12021639
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.
Bullingham R; Monroe S; Nicholls A; Hale M
J Clin Pharmacol; 1996 Apr; 36(4):315-24. PubMed ID: 8728345
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
Jain A; Venkataramanan R; Hamad IS; Zuckerman S; Zhang S; Lever J; Warty VS; Fung JJ
J Clin Pharmacol; 2001 Mar; 41(3):268-76. PubMed ID: 11269567
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.
Gimenez F; Foeillet E; Bourdon O; Weller S; Garret C; Bidault R; Singlas E
Clin Pharmacokinet; 2004; 43(10):685-92. PubMed ID: 15244498
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
